Pfizer asks FDA to authorize COVID vaccine for kids 6 months through 4 years

At the FDA's request, Pfizer has started a rolling authorization process for its COVID vaccine for kids under 5.

April 15, 2025 · 1 min · 58 words · Scott Adams

Children age 5 and upare already eligible for a COVID-19 vaccine.

This prompted the company to start testing a three-dose version of the vaccine for children under age 5.

The vaccine for kids ages 5 to 11 is one-third the adult size.

There wereno safety concernsreported in Pfizer’s trial for children under 5, the company said in December.